Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

GS-443902 (trisodium)

GS-443902 trisodium (GS-441524 triphosphate trisodium) is a potent viral RNA-dependent RNA-polymerases (RdRp) inhibitor with IC50s of 1.1 μM, 5 μM for RSV RdRp and HCV RdRp, respectively. GS-443902 trisodium is the active triphosphate metabolite of Remdesivir (GS-5734) [1][2].

Product Specifications

CAS Number

1355050-21-3

Product Name Alternative

GS-441524 triphosphate (trisodium) ; Remdesivir metabolite (trisodium)

UNSPSC

12352005

Target

DNA/RNA Synthesis; Drug Metabolite; HCV; RSV; SARS-CoV

Type

Reference compound

Related Pathways

Anti-infection; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease

Applications

COVID-19-anti-virus

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/gs-443902-trisodium.html

Purity

99.98

Solubility

H2O : 33.33 mg/mL (ultrasonic)

Smiles

O=P(OP(O)(O[Na])=O)(O[Na])OP(OC[C@@H](O1)[C@@H](O)[C@@H](O)[C@]1(C#N)C2=CC=C3N2N=CN=C3N)(O[Na])=O

Molecular Formula

C12H13N5Na3O13P3

Molecular Weight

597.15

References & Citations

[1]Warren TK, et al. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature. 2016 Mar 17;531 (7594) :381-5.|[2]Siegel D, et al. Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses. Med Chem. 2017 Mar 9;60 (5) :1648-1661.|[3]Cho A, et al. Synthesis and antiviral activity of a series of 1'-substituted 4-aza-7,9-dideazaadenosine C-nucleosides. Bioorg Med Chem Lett. 2012 Apr 15;22 (8) :2705-7.

Shipping Conditions

Dry Ice

Storage Conditions

-80°C, protect from light, stored under nitrogen

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Citation 01

BioRxiv. 2021 Jul 21:2021.07.21.453274. |J Control Release. 2025 Sep 18:387:114245.|J Med Chem. 2024 May 9;67 (9) :7470-7486.|Nat Commun. 2021 Oct 4;12 (1) :5811.|Sci Rep. 2022 Nov 2;12 (1) :18506.|Acta Pharm Sin B. 2021 Jun;11 (6) :1607-1616.|Cell. 2022 Nov 10;185 (23) :4347-4360.e17.|Chem Biol Interact. 2021 Jul 1:343:109480.|Curr Res Pharmacol Drug Discov. 2021:2:100045.|EMBO J. 2025 Jan;44 (2) :563-586.|Int J Mol Sci. 2022 Jul 27;23 (15) :8302.|J Med Chem. 2025 Jun 26;68 (12) :12414-12433.|Research Square Preprint. 2022 May.

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

CD106 / VCAM1 (B-K9), CF568 conjugate, 0.1mg/mL
BNC680304-100 1x 100 µL

CD106 / VCAM1 (B-K9), CF568 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
MUC2 (CCP58), CF568 conjugate, 0.1mg/mL
BNC680032-100 1x 100 µL

MUC2 (CCP58), CF568 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD10 (CB-CALLA), CF488A conjugate, 0.1mg/mL
BNC880146-500 1x 500 µL

CD10 (CB-CALLA), CF488A conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD50 (ICAM-3) (186-2G9), CF640R conjugate, 0.1mg/mL
BNC400178-100 1x 100 µL

CD50 (ICAM-3) (186-2G9), CF640R conjugate, 0.1mg/mL

Sign In for Pricing
View Details
P53 (PAb122), CF405S conjugate, 0.1mg/mL
BNC040338-100 1x 100 µL

P53 (PAb122), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details
SUMO-1 (SUMO1/1188), CF640R conjugate, 0.1mg/mL
BNC401188-100 1x 100 µL

SUMO-1 (SUMO1/1188), CF640R conjugate, 0.1mg/mL

Sign In for Pricing
View Details